Atopic dermatitis in children: a cross-sectional study of its impact on quality of life
DOI:
https://doi.org/10.18203/2349-3291.ijcp20240731Keywords:
Atopic dermatitis, Quality of life, SCORAD, CDLQI, IDQOLAbstract
Background: Atopic dermatitis, characterized by chronic inflammation of the skin, manifests with symptoms such as itching, skin discomfort, and sleep disturbances, significantly impacting the physical health and daily functioning of affected children. We embarked on this study to assess the Quality of Life of children with AD, identify factors that influence their QoL, and determine the specific domains of QoL most affected by the condition.
Methods: Children up to 16 years of age, who met the Hanifin and Rajka’s diagnostic criteria for AD, were identified. The severity of AD was assessed using the severity scoring of atopic dermatitis index, and QoL was assessed using validated questionnaires: the infants dermatitis quality of life index for children under 4 years and the children’s dermatology life quality index for children 4 years and above.
Results: A total of 70 children with AD were enrolled in the study. The mean QoL (IDQOL/CDLQI) score for children with AD was 6.7±5.05 and QoL was significantly impaired in children with more severe disease. The domains of QoL most affected by AD were related to pruritus, sleep disturbances, mood changes and treatment related issues. The duration of illness and the presence of other atopic comorbidities showed a significant correlation with QoL impairment, whereas age, gender and socioeconomic status demonstrated no such correlation.
Conclusions: This study highlights the substantial impact of AD on the QoL of affected children, especially due to symptoms like itching and sleep disturbances.
Metrics
References
Kanwar AJ, De D. Epidemiology and clinical features of atopic dermatitis in India. Indian J Dermatol. 2011; 56(5):471.
Puddicombe OT, Odusote OA, Lesi FE, Ayanlowo AO. Impact of atopic dermatitis on the quality of life of Nigerian children: A hospital-based cross-sectional study. South Afr J Child Health. 2018;12(4):137-42.
Kim J, Kim BE, Leung DY. Pathophysiology of atopic dermatitis: clinical implications. In: Allergy and asthma proceedings. USA: Ocean Side Publications; 2019:40(2);84.
Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-51.
Wisuthsarewong W, Nitiyarom R, Boonpuen N. Childhood Atopic Dermatitis: Impact on Quality of Life in Thai Children and their Families. Astrocyte. 2017;4(3):144.
Monti F, Agostini F, Gobbi F, Neri E, Schianchi S, Arcangeli F. Quality of life measures in Italian children with atopic dermatitis and their families. Italian J Pediatr. 2011;37(1):59.
Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Investigat Dermatol. 2017;137(1):26-30.
Schmitt J, Apfelbacher C, Spuls PI, Thomas KS, Simpson EL, Furue M, et al. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. J Investigat Dermatol. 2015;135(1):24-30.
Joji TA. Diagnostic standard for atopic dermatitis. JMA Pol. 2002;45(11):460-5.
Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997; 195(1):10-9.
Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol. 2000;136(6):763-9.
Rehal B, Armstrong A. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. PloS One. 2011;6(4):e17520.
Lewis‐Jones MS, Finlay AY. The children's dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942-9.
Lewis‐Jones MS, Finlay AY, Dykes PJ. The infants’ dermatitis quality of life index. Br J Dermatol. 2001;144(1):104-10.
Kumar S, Nayak CS, Padhi T, Rao G, Rao A, Sharma VK, et al. Epidemiological pattern of psoriasis, vitiligo and atopic dermatitis in India: Hospital-based point prevalence. Indian Dermatol J. 2014;5(1):S6.
Beattie PE, Lewis‐Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155(1):145-51.
Shariati M, Nasiri KR, Abaei HS, Goodarzi E, Hasanzadeh J, Ataee P, et al. The impact Atopic dermatitis on the life quality of childrens 1-6 year. Int J Pediatr. 2018;6(1):7003-11.
Hassab-El-Naby HM, Mohamed YF, Ammar MA, Mostafa AM. Assessment of quality of life among school children with atopic dermatitis in a locality in Cairo. J Egypt Women’s Dermatol Soc. 2011;8(1):7-10.
Ben‐Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol. 2004;150(2):284-90.
Van Valburg RW, Willemsen MG, Dirven-Meijer PC, Oranje AP, Van der Wouden JC, Moed H. Quality of life measurement and its relationship to disease severity in children with atopic dermatitis in general practice. Acta Dermatol Venereol. 2011;91(2):147-51.
Ghani AA, Noor NM, Muhamad R, Ismail Z. Quality of life and its associated factors among children with atopic eczema in Kelantan, Malaysia. Int J Collab Res Int Med Public Health. 2012;4(11):10.
Đurović MR, Janković J, Spirić VT, Relić M, Timotijević ZS, Ćirković A, et al. Does age influence the quality of life in children with atopic dermatitis?. PloS One. 2019;14(11):23-9.
Chernyshov PV. Gender differences in health‐related and family quality of life in young children with atopic dermatitis. Int J Dermatol. 2012;51(3):290-4.
Kiebert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, et al. Atopic dermatitis is associated with a decrement in health‐related quality of life. Int J Dermatol. 2002;41(3):151-8.